290 related articles for article (PubMed ID: 33173344)
21. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature.
Ota T; Sakashita K; Sawada R; Seki K; Maeda H; Tanaka N; Tsujinaka T
Surg Case Rep; 2023 May; 9(1):71. PubMed ID: 37150760
[TBL] [Abstract][Full Text] [Related]
23. The Effectiveness of Hepatic Arterial Infusion Chemotherapy with 5-Fluorouracil/Cisplatin and Systemic Chemotherapy with Ramucirumab in Alpha-Fetoprotein-Producing Gastric Cancer with Multiple Liver Metastases.
Doi Y; Takii Y; Mitsugi K; Kimura K; Mihara Y
Case Rep Oncol Med; 2018; 2018():5402313. PubMed ID: 30534453
[TBL] [Abstract][Full Text] [Related]
24. α-fetoprotein-producing gastric carcinoma: A case report of a rare subtype and literature review.
Sun N; Sun Q; Liu Q; Zhang T; Zhu Q; Wang W; Cao M; Zang QI
Oncol Lett; 2016 May; 11(5):3101-3104. PubMed ID: 27123071
[TBL] [Abstract][Full Text] [Related]
25. Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer.
Wang L; Feng Y; Huang A; Shi J; Zhang Q; Zhu F; Lv B; Guo F; Zou T; Zhang L
Front Oncol; 2022; 12():962126. PubMed ID: 36387141
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study.
Yan Y; Li H; Wu S; Wang G; Luo H; Niu J; Cao L; Hu X; Xu H; Jia W; Sun Y; Yao Y; Chen W; Ke L; Hu B; Ji C; Sun Y; Chen J; Li M; He Y
Ann Transl Med; 2022 Feb; 10(4):205. PubMed ID: 35280426
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologial features of gastric hepatoid adenocarcinoma.
Lin CY; Yeh HC; Hsu CM; Lin WR; Chiu CT
Biomed J; 2015; 38(1):65-9. PubMed ID: 25163499
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic features and prognosis of 51 patients with α-fetoprotein-producing gastric cancer].
Liu X; Yang M; Gao J; Zhang S; Xi Y
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):231-4. PubMed ID: 25975796
[TBL] [Abstract][Full Text] [Related]
29. Recurrent metastatic patterns and prognosis after radical surgery in patients with alpha-fetoprotein-producing gastric cancer: a retrospective cohort study.
Zhang F; Zhang X; Zhang X; Wang Y; Li T; Guo H; Ding P; Tian Y; Yang P; Li X; Meng N; Guo Z; Zhao Q; Zhang R
Am J Cancer Res; 2024; 14(5):2124-2140. PubMed ID: 38859826
[TBL] [Abstract][Full Text] [Related]
30. Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysis.
Cao R; Ma JT; Zhang SL; Sun L; Liu Y; Zhang XY; Jing W; Huang LT; Han CB
Cancer Med; 2019 Sep; 8(11):5033-5046. PubMed ID: 31297962
[TBL] [Abstract][Full Text] [Related]
31. Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.
Nakao S; Nakata B; Tendo M; Kuroda K; Hori T; Inaba M; Hirakawa K; Ishikawa T
BMC Surg; 2015 Jan; 15(1):5. PubMed ID: 25591731
[TBL] [Abstract][Full Text] [Related]
32.
Maruyama S; Furuya S; Shiraishi K; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
World J Gastrointest Oncol; 2018 Oct; 10(10):344-350. PubMed ID: 30364858
[TBL] [Abstract][Full Text] [Related]
33. Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy.
Reck M; Syrigos K; Miliauskas S; Zöchbauer-Müller S; Fischer JR; Buchner H; Kitzing T; Kaiser R; Radonjic D; Kerr K
Lung Cancer; 2020 Oct; 148():159-165. PubMed ID: 32927350
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the efficacy and prognostic factors of PD-1 inhibitors in advanced gallbladder cancer.
Zheng Q; Wu C; Ye H; Xu Z; Ji Y; Rao J; Lu L; Zhu Y; Cheng F
Ann Transl Med; 2021 Oct; 9(20):1568. PubMed ID: 34790774
[TBL] [Abstract][Full Text] [Related]
35. [The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
Wang YK; Shen L; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):514-517. PubMed ID: 28728297
[No Abstract] [Full Text] [Related]
36. First-line chemotherapy or in combination with programmed cell death protein-1 antibody in patients with metastatic or recurrent biliary tract cancer.
Zhao S; Guo XG; Zhang D; Zhou G; Song P; Yang J; Zhang Y; Li P; Hu Y; Wang P
J Gastroenterol Hepatol; 2021 Dec; 36(12):3541-3547. PubMed ID: 34423859
[TBL] [Abstract][Full Text] [Related]
37. Hepatoid adenocarcinoma of the stomach is a special and easily misdiagnosed or missed diagnosed subtype of gastric cancer with poor prognosis but curative for patients of pN0/1: the experience of a single center.
Xie Y; Zhao Z; Li P; Wang Y; Guo C; Wang X; Tang W; Liu Q; Lu N; Xue L; Zhao D
Int J Clin Exp Med; 2015; 8(5):6762-72. PubMed ID: 26221214
[TBL] [Abstract][Full Text] [Related]
38. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
39. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.
Zhang B; Qi L; Wang X; Xu J; Liu Y; Mu L; Wang X; Bai L; Huang J
Cancer Commun (Lond); 2020 Dec; 40(12):711-720. PubMed ID: 33314747
[TBL] [Abstract][Full Text] [Related]
40. Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.
Hou Z; Xie J; Zhang L; Dai G; Chen Y; He L
Front Oncol; 2021; 11():702216. PubMed ID: 34422656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
